Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Microbio Co Ltd Receives Approval of New Drug Application for Chemo Young (oral solution)


Monday, 22 Jul 2013 08:43pm EDT 

Microbio Co Ltd announced that it has received the approval of New Drug Application from Department of Health, for its Chemo Young (oral solution), which is a cancer adjuvant chemotherapy. 

Company Quote

28.4
0.05 +0.18%
27 Dec 2014